vs
Boxlight Corp（BOXL）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是Boxlight Corp的1.2倍（$35.5M vs $29.3M），Boxlight Corp净利率更高（-21.1% vs -304.2%，领先283.2%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -19.2%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -23.1%）
Boxlight Corp是全球互动技术解决方案供应商，主营交互式平板显示器、投影仪、协作软件及教育技术配件，主要服务K12、高等教育机构及企业、政府客户，产品覆盖北美、欧洲、亚太等市场，专注提升教学及协作效率。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BOXL vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.2倍
$29.3M
营收增速更快
RXRX
高出700.9%
-19.2%
净利率更高
BOXL
高出283.2%
-304.2%
两年增速更快
RXRX
近两年复合增速
-23.1%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $29.3M | $35.5M |
| 净利润 | $-6.2M | $-108.1M |
| 毛利率 | 29.1% | 59.8% |
| 营业利润率 | -13.4% | -304.8% |
| 净利率 | -21.1% | -304.2% |
| 营收同比 | -19.2% | 681.7% |
| 净利润同比 | -102.0% | 39.6% |
| 每股收益（稀释后） | $-1.88 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BOXLRXRX
| Q4 25 | — | $35.5M | ||
| Q3 25 | $29.3M | $5.2M | ||
| Q2 25 | $30.9M | $19.2M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | $24.0M | $4.5M | ||
| Q3 24 | $36.3M | $26.1M | ||
| Q2 24 | $38.5M | $14.4M | ||
| Q1 24 | $37.1M | $13.8M |
净利润BOXLRXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-6.2M | $-162.3M | ||
| Q2 25 | $-4.7M | $-171.9M | ||
| Q1 25 | — | $-202.5M | ||
| Q4 24 | $-16.7M | $-178.9M | ||
| Q3 24 | $-3.1M | $-95.8M | ||
| Q2 24 | $-1.5M | $-97.5M | ||
| Q1 24 | $-7.1M | $-91.4M |
毛利率BOXLRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | 29.1% | -183.8% | ||
| Q2 25 | 35.0% | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | 30.6% | -181.4% | ||
| Q3 24 | 33.8% | 53.7% | ||
| Q2 24 | 37.7% | 36.2% | ||
| Q1 24 | 34.5% | 19.1% |
营业利润率BOXLRXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -13.4% | -3327.6% | ||
| Q2 25 | -12.7% | -916.8% | ||
| Q1 25 | — | -1297.9% | ||
| Q4 24 | -67.6% | -4042.4% | ||
| Q3 24 | -2.4% | -377.1% | ||
| Q2 24 | 3.2% | -697.4% | ||
| Q1 24 | -9.7% | -698.4% |
净利率BOXLRXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -21.1% | -3135.3% | ||
| Q2 25 | -15.3% | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | -69.6% | -3935.5% | ||
| Q3 24 | -8.4% | -367.5% | ||
| Q2 24 | -3.8% | -676.6% | ||
| Q1 24 | -19.1% | -662.4% |
每股收益（稀释后）BOXLRXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-1.88 | $-0.36 | ||
| Q2 25 | $-1.53 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | $-87.29 | $-0.56 | ||
| Q3 24 | $-1.72 | $-0.34 | ||
| Q2 24 | $-0.92 | $-0.40 | ||
| Q1 24 | $-0.76 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.8M | $743.3M |
| 总债务越低越好 | $36.7M | $9.6M |
| 股东权益账面价值 | $-19.5M | $1.1B |
| 总资产 | $99.6M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资BOXLRXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $11.8M | $659.8M | ||
| Q2 25 | $7.6M | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | $8.0M | $594.4M | ||
| Q3 24 | $10.5M | $427.6M | ||
| Q2 24 | $7.5M | $474.3M | ||
| Q1 24 | $11.8M | $296.3M |
总债务BOXLRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | $36.7M | $11.9M | ||
| Q2 25 | $39.0M | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $37.1M | $19.0M | ||
| Q3 24 | $38.8M | $20.5M | ||
| Q2 24 | $40.3M | $22.9M | ||
| Q1 24 | $38.5M | — |
股东权益BOXLRXRX
| Q4 25 | — | $1.1B | ||
| Q3 25 | $-19.5M | $1.0B | ||
| Q2 25 | $-20.6M | $919.1M | ||
| Q1 25 | — | $933.9M | ||
| Q4 24 | $-12.9M | $1.0B | ||
| Q3 24 | $6.5M | $524.6M | ||
| Q2 24 | $7.5M | $584.4M | ||
| Q1 24 | $9.1M | $401.2M |
总资产BOXLRXRX
| Q4 25 | — | $1.5B | ||
| Q3 25 | $99.6M | $1.4B | ||
| Q2 25 | $99.2M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $115.3M | $1.4B | ||
| Q3 24 | $142.9M | $726.5M | ||
| Q2 24 | $141.3M | $775.9M | ||
| Q1 24 | $142.4M | $557.8M |
负债/权益比BOXLRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 5.93× | 0.04× | ||
| Q2 24 | 5.38× | 0.04× | ||
| Q1 24 | 4.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
经营现金流BOXLRXRX
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $1.3M | $-117.4M | ||
| Q2 25 | — | $-76.4M | ||
| Q1 25 | — | $-132.0M | ||
| Q4 24 | $1.6M | $-115.4M | ||
| Q3 24 | $5.2M | $-59.2M | ||
| Q2 24 | $-5.4M | $-82.2M | ||
| Q1 24 | $-1.9M | $-102.3M |
自由现金流BOXLRXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
自由现金流率BOXLRXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
资本支出强度BOXLRXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOXL
| Products | $27.4M | 93% |
| Services | $2.0M | 7% |
RXRX
暂无分部数据
